KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Gevo (GEVO) Research & Development (2016 - 2025)

Gevo (GEVO) has disclosed Research & Development for 16 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development rose 1.33% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.6 million, a 18.4% decrease, with the full-year FY2025 number at $4.6 million, down 18.4% from a year prior.
  • Research & Development was $1.3 million for Q4 2025 at Gevo, up from $1.3 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $2.7 million in Q4 2022 to a low of $934000.0 in Q2 2025.
  • A 5-year average of $1.5 million and a median of $1.4 million in 2021 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: soared 137.59% in 2021, then tumbled 43.08% in 2025.
  • Gevo's Research & Development stood at $2.5 million in 2021, then grew by 8.37% to $2.7 million in 2022, then decreased by 29.04% to $1.9 million in 2023, then tumbled by 33.68% to $1.3 million in 2024, then rose by 1.33% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for GEVO's Research & Development are $1.3 million (Q4 2025), $1.3 million (Q3 2025), and $934000.0 (Q2 2025).